Breast Cancer Clinical Trial
Official title:
Facilitating Adjustment in Low Income Black Women With Breast Cancer
The main goal of the proposed study is to test whether a successful stress management
intervention can be effectively implemented in natural settings in the community and will be
acceptable to a community dwelling, low income population of African American women with
breast cancer.
Hypothesis 1: There will be no differences between women randomized to either the Cognitive
Behavioral Stress Management (CBSM) or the Cancer Wellness and Education condition (CW) on
ratings of acceptability of the program.
Hypothesis 2: Women randomized to the CBSM condition will show greater decreases over time
in cancer-specific distress and greater increases over time in quality of life as compared
to women in the CW condition over the course of the study from baseline to six month
follow-up.
Hypothesis 3: Women randomized to the CBSM condition will show greater improvement in pain
levels, sleep disturbance and fatigue as compared to women in the CW condition over the
course of the study from baseline to six month follow-up.
Hypothesis 4: Women randomized to the CBSM condition will report fewer sick days, earlier
return to work, fewer unanticipated health care visits, fewer visits to the Emergency
Department and better follow-up with oncologists as compared to women in the CW condition
over the course of the study from baseline to six month follow-up.
Hypothesis 5: Women randomized to the CBSM condition will show more normalized patterns of
diurnal cortisol (e.g., greater increase in negative AM-PM slope) as compared to women in
the CW condition over the course of the study from baseline to six month follow-up.
Hypothesis 6: Women randomized to the CBSM condition will show more less normalized patterns
of heart rate variability (e.g., more variation) as compared to women in the CW condition
over the course of the study from baseline to six month follow-up.
Minority women are grossly underserved and suffer poorer quality of life during and after
treatment for breast cancer. Despite this greater need, interventions designed to foster
adaptation to disease among such women are scarce. Our recent randomized trial tested the
efficacy of a 10-week multi-modal, group-based, cognitive behavioral stress management
(CBSM) intervention delivered in a university setting among women with breast cancer who
recently completed adjuvant treatment. Using a panel of psychological, physiological, and
physical indicators of adaptation, the investigators examined whether the intervention
facilitated "recovery" or adaptation after adjuvant therapy for breast cancer had been
completed. CBSM intervention participants showed improvements in multiple indicators of
psychosocial adaptation (fewer intrusive thoughts, lower anxiety, less social disruption,
less negative affect, more positive affect, greater benefit finding, and higher levels of
positive states of mind), physiological adaptation (decreased cortisol and increased
cellular immune function and Th1 cytokine production) and physical adaptation to disease
(less fatigue and improved sleep quality). Many of these findings held at 3 and 9 month
follow-ups. As with most psychosocial oncology research, participants in the randomized
trial were mostly non-Hispanic White women. Whether or not the results of that trial are
generalizable to the larger population that includes minority women needs to be tested.
The proposed research aims to translate this University-based, CBSM intervention into a
format that will be acceptable and effective in a community setting. The investigators will
target our efforts toward low-income African American women, (n=120 after attrition)
diagnosed with breast cancer (all stages of disease). Participants will be randomized to
10-week CBSM intervention or an attention time-matched Enhanced Breast Cancer Wellness and
Education (CW) active comparison-control condition and monitored for 6 months afterward.
Outcomes include: (a) acceptability of the intervention, (b) psychosocial adaptation, (c)
physical symptom clusters, (d) economic implications and (e) an objective indicator of
stress (diurnal salivary cortisol). The main goal is to test whether a successful
stress-management intervention can be effectively implemented in natural settings in the
community and will be acceptable to a community-dwelling, low-income population of African
American women with breast cancer.
Specific Aim 1: To examine the acceptability of an empirically-validated stress management
intervention in community-dwelling low-income African American women with breast cancer.
Specific Aim 2: To test the prediction that participants randomized to CBSM intervention
show significant improvements in indices of psychosocial adaptation (i.e., cancer-specific
distress, quality of life) relative to women randomized to a CW attention control condition
across the study period.
Specific Aim 3: To test the prediction that participants randomized to CBSM intervention
show significant improvements in indices of physical symptom clusters relative to women
randomized to a CW attention control condition across the study period (physical symptom
clusters include pain, sleep, fatigue).
Specific Aim 4: To test the prediction that women randomized to a CBSM intervention versus
CW attention control condition have better economic outcomes across the study period (as
measured by faster return to work, fewer sick days, fewer health care visits).
Specific Aim 5: To test the prediction that participants randomized to CBSM intervention
show significant improvements in indices of physiological adaptation relative to women
randomized to a CW attention control condition across the study period by examining diurnal
salivary cortisol as objective measure of stress.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |